Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
DVQ1F5
|
|||
| Drug Name |
CMN-001
|
|||
| Drug Type |
Cell therapy
|
|||
| Indication | Renal cell carcinoma [ICD-11: 2C90; ICD-10: C64; ICD-9: 189] | Phase 2 | [1] | |
| Company |
CoImmune Durham, NC
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT04203901) A Phase 2b Randomized Trial of Autologous Dendritic Cell Immunotherapy (CMN-001) Plus Standard Treatment of Advanced Renal Cell Carcinoma. U.S.National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.